share_log

HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $11

Benzinga ·  Nov 10, 2023 23:27

HC Wainwright & Co. analyst Yi Chen maintains ProPhase Labs (NASDAQ:PRPH) with a Buy and lowers the price target from $14 to $11.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment